Phase I Chinese PK
This study has been completed.
Information provided by:
First received: July 18, 2007
Last updated: March 11, 2010
Last verified: March 2009
An open, phase 1 to assess the PK of rising doses of ZD6474 when administered daily in Chinese patients with advanced solid malignant tumors.
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||An Open Label, Phase I, Rising Multiple Dose, Single Centre Study to Determine the PK and Tolerability of ZD6474 at Different Dose Levels in Chinese Patients With Solid Malignancy Tumor|
Resource links provided by NLM:
Further study details as provided by AstraZeneca:
Contacts and Locations